Guidance for market authorization requirements for COVID-19 vaccines: Review process, communications and transparency

Description

Decisions made about COVID-19 vaccines will follow processes established for reviews under the modified requirements for COVID-19 drugs. Health Canada will start rolling reviews to build towards a complete dossier for each vaccine. The dossier will include data to support the safety, efficacy and quality of the proposed vaccine.

Resources

Name Format Description Link
Guidance for market authorization requirements for COVID-19 vaccines: Review process, communications and transparency HTML https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/guidance-market-authorization-vaccines/review-process-communications-transparency.html
Guidance for market authorization requirements for COVID-19 vaccines: Review process, communications and transparency HTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/ligne-directrices-autorisations-mise-marche-vaccins/processus-examen-communications-transparence.html

Tags

Topics

Categories